See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

Gene Modified EPCs for STEMI

Presenter: Michael Kutryk

January 22, 2014

Presentation

Causes of Short-term Readmission After PCI

Presenter: J.H. Wasfy

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

RETRO-HF

Presenter: Amit N. Patel

January 22, 2014

Presentation Cell Therapy 2014

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

HGF for Critical Limb Ischemia

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation Cell Therapy 2014

The Acute Myocardial Infarction Studies of the Cardiovascular Cell Therapy Research Network (CCTRN)

Presenter: Jay H. Traverse

January 22, 2014

Presentation Cell Therapy 2014

LV Augmentation for the Treatment of Heart Failure

Presenter: Randy Lee

January 22, 2014

Advertisement

Slides

Gene Modified EPCs for STEMI

Causes of Short-term Readmission After PCI

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

RETRO-HF

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

HGF for Critical Limb Ischemia

Clinical Trials in Peripheral Arterial Disease

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

The Acute Myocardial Infarction Studies of the Cardiovascular Cell Therapy Research Network (CCTRN)

LV Augmentation for the Treatment of Heart Failure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content